• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (6)
    • Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study.
    • GATA4 is essential for jejunal function in mice.
    • Mechanisms and Risk Factors Contributing to Visual Field Deficits following Stereotactic Laser Amygdalohippocampotomy.
    • The neurocircuitry of addiction: an overview.
    • Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
    • See All 6 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer. N Engl J Med. 2019 12 19; 381(25):2391-2402.

View in: PubMed

subject areas
  • Administration, Oral
  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents
  • Combined Modality Therapy
  • Double-Blind Method
  • Female
  • Humans
  • Indazoles
  • Maintenance Chemotherapy
  • Middle Aged
  • Nausea
  • Ovarian Neoplasms
  • Piperidines
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Quality of Life
  • Survival Analysis

authors with profiles
  • Whitney S Graybill